156 related articles for article (PubMed ID: 25577816)
1. Noninvasive prenatal cell-free fetal DNA-based screening for aneuploidies other than trisomy 21.
Blue Cross Blue Shield Asssociation
Technol Eval Cent Assess Program Exec Summ; 2014 Dec; 29(7):1-7. PubMed ID: 25577816
[No Abstract] [Full Text] [Related]
2. [Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].
Bijok J; Gorzelnik K; Massalska D; Ilnicka A; Pawłowska B; Zimowski JG; Kucińska-Chahwan A; Jakiel G; Roszkowski T
Ginekol Pol; 2014 Mar; 85(3):208-13. PubMed ID: 24783433
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis.
Gil MM; Akolekar R; Quezada MS; Bregant B; Nicolaides KH
Fetal Diagn Ther; 2014; 35(3):156-73. PubMed ID: 24513694
[TBL] [Abstract][Full Text] [Related]
5. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of semiconductor sequencing for noninvasive prenatal detection of fetal aneuploidy.
Yuan Y; Jiang F; Hua S; Du B; Hao Y; Ye L; Liu J; Feng K; Huang X; Yi X; Wang W; Yang L; Mu F; Liu C; Liang Y
Clin Chem; 2013 May; 59(5):846-9. PubMed ID: 23364181
[TBL] [Abstract][Full Text] [Related]
7. Clinical perspective of cell-free DNA testing for fetal aneuploidies.
Gratacós E; Nicolaides K
Fetal Diagn Ther; 2014; 35(3):151-5. PubMed ID: 24931002
[TBL] [Abstract][Full Text] [Related]
8. Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA.
BlueCross BlueShield Association
Technol Eval Cent Assess Program Exec Summ; 2013 Apr; 27(10):1-6. PubMed ID: 23866392
[No Abstract] [Full Text] [Related]
9. [Impact of maternal X chromosome aneuploidies on cell free DNA prenatal screening].
Chang JZ; Qi QW; Zhou XY; Jiang YL; Hao N; Zhou J; Li MM; Tian XT; Liu JT
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):100-105. PubMed ID: 32146738
[No Abstract] [Full Text] [Related]
10. Cell-free DNA screening and sex chromosome aneuploidies.
Mennuti MT; Chandrasekaran S; Khalek N; Dugoff L
Prenat Diagn; 2015 Oct; 35(10):980-5. PubMed ID: 26088741
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X.
Yao H; Zhang L; Zhang H; Jiang F; Hu H; Chen F; Jiang H; Mu F; Zhao L; Liang Z; Wang W
Prenat Diagn; 2012 Nov; 32(11):1114-6. PubMed ID: 22903289
[No Abstract] [Full Text] [Related]
12. [Summary of 2012 experts symposium about new technology of prenatal molecular diagnosis].
Jiang YL; Zhu YN; Lü SM
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):804-7. PubMed ID: 23302118
[No Abstract] [Full Text] [Related]
13. Rapid prenatal diagnosis of aneuploidy using quantitative fluorescence-PCR (QF-PCR).
Ogilvie CM; Donaghue C; Fox SP; Docherty Z; Mann K
J Histochem Cytochem; 2005 Mar; 53(3):285-8. PubMed ID: 15750003
[TBL] [Abstract][Full Text] [Related]
14. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.
Liang D; Lv W; Wang H; Xu L; Liu J; Li H; Hu L; Peng Y; Wu L
Prenat Diagn; 2013 May; 33(5):409-15. PubMed ID: 23299662
[TBL] [Abstract][Full Text] [Related]
16. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.
Nicolaides KH; Syngelaki A; Gil M; Atanasova V; Markova D
Prenat Diagn; 2013 Jun; 33(6):575-9. PubMed ID: 23613152
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
[TBL] [Abstract][Full Text] [Related]
18. Introduction of the QF-PCR analysis for the purposes of prenatal diagnosis in Bulgaria--estimation of applicability of 6 STR markers on chromosomes 21 and 18.
Andonova S; Vazharova R; Dimitrova V; Mazneikova V; Toncheva D; Kremensky I
Prenat Diagn; 2004 Mar; 24(3):202-8. PubMed ID: 15057954
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
Grati FR; Ferreira JC; Bajaj K
Am J Obstet Gynecol; 2014 Dec; 211(6):711-2. PubMed ID: 25025943
[No Abstract] [Full Text] [Related]
20. Rapid prenatal diagnosis of aneuploidy for chromosomes 21, 18, 13, and X by quantitative fluorescence polymerase chain reaction.
Ochshorn Y; Bar-Shira A; Jonish A; Yaron Y
Fetal Diagn Ther; 2006; 21(4):326-31. PubMed ID: 16757905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
